Women's Ischemia Syndrome Evaluation - WISE

Description:

The goal of the National Heart, Lung and Blood Institute–sponsored Women’s Ischemia Syndrome Evaluation (WISE) study is to: 1) optimize symptom evaluation and diagnostic testing for ischemic heart disease; 2) explore mechanisms for symptoms and myocardial ischemia in the absence of epicardial coronary artery stenoses, and 3) evaluate the influence of reproductive hormones on symptoms and diagnostic test response.